North Korean Pharma Output Up 10% In 1996

16 December 1996

The production of pharmaceuticals in North Korea increased by around 10% in 1996 over 1995, reports the KCNA news agency, quoting official sources in Pyongyang.

This higher production was facilitated by increased output at existing pharmaceutical facilities, as well as through the addition of new production capacities, particularly in Pyongyang, it says.

A number of new pharmaceutical brands were introduced onto the market, and an increase in drug exports was recorded, particularly to South-East Asia and countries with a relatively large ethnic Korean population, such as Japan.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight